Daniel P. O'Day
2021
Compensation breakdown
Non-Equity Incentive Plan | $3,446,190 |
---|---|
Option Awards | $3,375,004 |
Salary | $1,650,000 |
Stock Awards | $9,764,060 |
Other | $994,212 |
Total | $19,229,466 |
O'Day received $9.8M in stock awards, accounting for 51% of the total pay in 2021.
O'Day also received $3.4M in non-equity incentive plan, $3.4M in option awards, $1.7M in salary and $994.2K in other compensation.
Rankings
In 2021, Daniel P. O'Day's compensation ranked 351st out of 12,415 executives tracked by ExecPay. In other words, O'Day earned more than 97.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 351 out of 12,415 | 97th |
Division Manufacturing | 105 out of 5,508 | 98th |
Major group Chemicals And Allied Products | 33 out of 2,378 | 99th |
Industry group Drugs | 29 out of 2,099 | 99th |
Industry Biological Products, Except Diagnostic Substances | 13 out of 449 | 97th |
Pay ratio
Daniel P. O'Day's Pay | $19,229,466 |
---|---|
Median Employee's Pay | $211,687 |
Pay Ratio | 91to 1 |
In 2021, the annual total compensation of Daniel P. O'Day was $19,229,466.
The annual total compensation of the median employee at Gilead Sciences was $211,687.
The ratio of Daniel P. O'Day's pay to the pay of median employee was therefore 91 to one.
O'Day's colleagues
We found four more compensation records of executives who worked with Daniel P. O'Day at Gilead Sciences in 2021.